AB
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| How Using Different Oximeters May Affect Clinical Decision-Making : A Method Comparison Study in Patients Receiving CPAP or Noninvasive Ventilation | Chest | 2026 | 11 | 79 | |||
| Dyspnoea patterns in patients with advanced diseases : a functional MRI feasibility study protocol | BMJ open | 2026 | 14 | 19 | |||
| Contribution of paranasal sinus, chest, and abdomen/pelvis computed tomography in patients with febrile neutropenia | PloS one | 2025 | 8 | 65 | |||
| Générer ou guider ? Penser la recherche médicale face à l’IA générative | Revue médicale suisse | 2025 | 9 | 0 | |||
| An objective method to detect sighs during cardio-pulmonary exercise testing | Scientific reports | 2025 | 12 | 12 | |||
| Defining bloodstream and central venous catheter-related infections in patients following haematopoietic cell transplantation : position paper of the European Blood and Marrow Transplantation Society Infectious Diseases Working Party and Practice Harmonization and Guidelines Committee | Clinical microbiology and infection | 2025 | 2 | 0 | |||
| Lung stem cells and respiratory epithelial chimerism in transplantation | European respiratory review | 2025 | 19 | 74 | |||
| What's new in the management of pulmonary complications in allogeneic stem cell transplantation ? | Expert review of respiratory medicine | 2025 | 11 | 17 | |||
| Pneumonia definition in allogeneic hematopoietic cell transplant recipients : Update and challenges in 2024. Recommendations from the EBMT Infectious Diseases Working Party and Practice Harmonization and Guidelines committee | Current research in translational medicine | 2025 | 10 | 23 | |||
| Maladie inflammatoire chronique de l’intestin et atteinte pulmonaire | Revue médicale suisse | 2025 | 14 | 0 | |||
| Translation into English and republication of : Pneumocystis jirovecii prophylaxis in non-HIV infected individuals : risk assessment and modalities | Respiratory medicine and research | 2025 | 5 | 89 | |||
| Breakthrough Invasive Mould Infections Under Posaconazole Prophylaxis in Patients With Haematologic Malignancies : A Case-Control Study | Mycoses | 2025 | 7 | 52 | |||
| Bronchiectasis in France : data on disease characteristics in 630 patients from the European Bronchiectasis registry (EMBARC) | Respiratory medicine and research | 2025 | 11 | 58 | |||
| Bronchiectasis after allogeneic hematopoietic cell transplantation - an underdiagnosed complication | Respiratory medicine | 2025 | 9 | 0 | |||
| Management of Invasive Pulmonary Aspergillosis in Intensive Care Units : Guidelines From the Fungal Infection Network of Switzerland (FUNGINOS) | Mycoses | 2025 | 10 | 287 | |||
| Video-Observed Therapy as an alternative to Directly-Observed Therapy for active tuberculosis : a prospective study of feasibility and acceptability by patients and nurses in a low-incidence high-income area | Swiss medical weekly | 2025 | 7 | 62 | |||
| Respiratory Burden in Hematology-Related Bronchiectasis : Clinical Characteristics and Treatable Traits | Respiration | 2025 | 8 | 38 | |||
| Efficacy and safety of DANAZOL for pulmonary fibrosis or bone marrow failure associated with telomere related gene mutation | ERJ open research | 2025 | 8 | 65 | |||
| Late-onset pulmonary complications following allogeneic hematopoietic cell transplantation in pediatric patients : a prospective multicenter study | Bone marrow transplantation | 2024 | 47 | 0 | |||
| Effect of cyclosporin A on respiratory viral replication in fully differentiated ex vivo human airway epithelia | Pharmacology research & perspectives | 2024 | 135 | 152 | |||
| Isavuconazole for the Treatment of Fungal Infections : A Real-life Experience From the Fungal Infection Network of Switzerland (FUNGINOS) | Open forum infectious diseases | 2024 | 83 | 195 | |||
| Detection of Bronchiolitis Obliterans Syndrome after Pediatric Hematopoietic Stem Cell Transplantation : An Official American Thoracic Society Clinical Practice Guideline | American journal of respiratory and critical care medicine | 2024 | 61 | 80 | |||
| Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials | EClinicalMedicine | 2024 | 98 | 22 | |||
| Adaptive multi-interventional trial platform to improve patient care for fibrotic interstitial lung diseases | Thorax | 2024 | 8 | 29 | |||
| CT Imaging Assessment of Response to Treatment in Allergic Bronchopulmonary Aspergillosis in Adults With Bronchial Asthma | Chest | 2024 | 61 | 49 | |||
| Prophylaxie de l’infection à Pneumocystis jirovecii chez les patients non VIH : Évaluation du risque et des modalités | Revue médicale suisse | 2024 | 72 | 0 | |||
| Human metapneumovirus infection is associated with a substantial morbidity and mortality burden in adult inpatients | Heliyon | 2024 | 102 | 122 | |||
| Diagnosis of Post-Hematopoietic Stem Cell Transplantation Bronchiolitis Obliterans Syndrome in Children : Time for a Rethink ? | Transplantation and cellular therapy | 2024 | 59 | 51 | |||
| Blood MMP-9 measured at 2 years after lung transplantation as a prognostic biomarker of chronic lung allograft dysfunction | Respiratory research | 2024 | 8 | 44 | |||
| ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft-versus-host disease in adults | The European respiratory journal | 2024 | 73 | 2,461 | |||
| Créer l’avenir… | Revue médicale suisse | 2024 | 11 | 0 | |||
| Noninfectious pulmonary complications | The EBMT Handbook : Hematopoietic Cell Transplantation and Cellular Therapies | 2024 | 86 | 147 | |||
| Recommendations for surveillance of pulmonary dysfunction among childhood, adolescent, and young adult cancer survivors : a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group | EClinicalMedicine | 2024 | 26 | 77 | |||
| Pulmonary fibrosis in patients with autoimmune pulmonary alveolar proteinosis: a retrospective nationwide cohort study | ERJ open research | 2024 | 70 | 160 | |||
| Nouveautés dans le diagnostic et le traitement de la pneumonie acquise en communauté | Revue médicale suisse | 2024 | 135 | 0 | |||
| Pitfalls in definitions on respiratory viruses and particularities of Adenovirus infection in hematopoietic cell transplantation patients : Recommendations from the EBMT practice harmonization and guidelines committee | Current research in translational medicine | 2024 | 53 | 107 | |||
| Inefficient antiviral response in reconstituted small-airway epithelium from chronic obstructive pulmonary disease patients following human parainfluenza virus type 3 infection | Virology journal | 2024 | 97 | 104 | |||
| Soins palliatifs précoces dans les maladies respiratoires chroniques | Revue internationale de soins palliatifs | 2023 | 64 | 0 | |||
| Interstitial lung diseases after hematopoietic stem cell transplantation: New pattern of lung chronic graft-versus-host disease ? | Bone marrow transplantation | 2023 | 126 | 220 | |||
| Respiratory recovery trajectories after severe-to-critical COVID-19: a 1-year prospective multicentre study | The European respiratory journal | 2023 | 98 | 127 | |||
| Infections in autoimmune pulmonary alveolar proteinosis: a large retrospective cohort | Thorax | 2023 | 88 | 0 | |||
| Bronchiolitis obliterans syndrome following SARS-CoV-2 infection in an allogeneic hematopoietic stem cell recipient | American journal of transplantation | 2023 | 308 | 262 | |||
| Late-Onset Interstitial Lung Disease Following Allogeneic Hematopoietic Stem Cell Transplantation | Pulmonary and Critical Care Considerations of Hematopoietic Stem Cell Transplantation | 2023 | 45 | 0 | |||
| 18F-FDG uptake by respiratory muscles in acute respiratory insufficiency in a patient with graft versus host disease | Respiratory medicine and research | 2023 | 96 | 0 | |||
| Impact of the COVID-19 pandemic on antiviral drug development for other community-acquired respiratory viruses’ infections | Thérapie | 2023 | 87 | 505 | |||
| Prise en charge palliative précoce de la dyspnée dans les maladies pulmonaires | Revue médicale suisse | 2023 | 111 | 74 | |||
| Liver disease in germline mutations of telomere-related genes : prevalence, clinical, radiological, pathological features, outcome, and risk factors | Hepatology | 2023 | 135 | 267 | |||
| Bronchial aspirate obtained during bronchoscopy yields increased fungal load compared to bronchoalveolar lavage fluid in patients at risk of invasive aspergillosis and Pneumocystis pneumonia | Medical mycology | 2023 | 118 | 0 | |||
| Quels défis pour la pneumologie de demain ? | Revue médicale suisse | 2023 | 7 | 8 | |||
| Bronchiolitis obliterans syndrome | Pulmonary and Critical Care Considerations of Hematopoietic Stem Cell Transplantation | 2023 | 28 | 0 | |||
| Immunocompromised Host Pneumonia: Definitions and Diagnostic Criteria: An Official American Thoracic Society Workshop Report | Annals of the American Thoracic Society | 2023 | 82 | 450 | |||
| Circulating T cell profiles associate with enterotype signatures underlying hematological malignancy relapses | Cell host & microbe | 2023 | 88 | 0 | |||
| 2022 Update of indications and contraindications for lung transplantation in France | Respiratory medicine and research | 2023 | 146 | 0 | |||
| Atypical imaging patterns during lung invasive mould diseases: lessons for clinicians | European respiratory review | 2023 | 113 | 111 | |||
| Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation | Blood | 2022 | 128 | 97 | |||
| Amikacin Liposomal Inhalation Suspension in the Treatment of Mycobacterium abscessus Lung Infection: A French Observational Experience | Open forum infectious diseases | 2022 | 146 | 157 | |||
| Déficit en alpha-1-antitrypsine | Revue médicale suisse | 2022 | 155 | 696 | |||
| Severe COVID-19 is associated with hyperactivation of the alternative complement pathway | Journal of allergy and clinical immunology | 2022 | 111 | 101 | |||
| Bronchiolitis obliterans syndrome after lung or haematopoietic stem cell transplantation: current management and future directions | ERJ open research | 2022 | 72 | 453 | |||
| Nebulised liposomal amphotericin-B as maintenance therapy in allergic bronchopulmonary aspergillosis: a randomised, multicentre trial | The European respiratory journal | 2022 | 191 | 0 | |||
| Unis pour être meilleurs | Revue médicale suisse | 2022 | 66 | 60 | |||
| Active Surveillance Program to Increase Awareness on Invasive Fungal Diseases: the French RESSIF Network (2012 to 2018) | MBio | 2022 | 98 | 290 | |||
| Epigenetic changes in human model KMT2A leukemias highlight early events during leukemogenesis | Haematologica | 2022 | 112 | 177 | |||
| Antifungal Prophylaxis in AML Patients Receiving Intensive Induction Chemotherapy: A Prospective Observational Study From the Acute Leukaemia French Association (ALFA) Group | Clinical lymphoma, myeloma and leukemia | 2022 | 84 | 0 | |||
| Mycobacterial infections in adults with haematological malignancies and haematopoietic stem cell transplants: guidelines from the 8th European Conference on Infections in Leukaemia | Lancet. Infectious diseases | 2022 | 126 | 0 | |||
| Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial | The Lancet. Rheumatology | 2022 | 19 | 12 | |||
| Transplantation pulmonaire en France : actualisation des indications et contre-indications en 2022 | Revue des maladies respiratoires | 2022 | 84 | 0 | |||
| Dasatinib dose optimisation based on therapeutic drug monitoring reduces pleural effusion rates in chronic myeloid leukaemia patients | British journal of haematology | 2021 | 35 | 0 | |||
| Evaluation of prognostic scores for respiratory syncytial virus infection in a French multicentre cohort of allogeneic haematopoietic stem cell transplantation recipients | Bone marrow transplantation | 2021 | 155 | 122 | |||
| National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report | Transplantation and cellular therapy | 2021 | 30 | 390 | |||
| Profiles and outcomes in patients with COVID-19 admitted to wards of a French oncohematological hospital : A clustering approach | PloS one | 2021 | 26 | 52 | |||
| Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases : a retrospective study from a French tertiary care hospital | Blood cancer journal | 2021 | 126 | 33 | |||
| Pulmonary hypertension in patients with common variable immunodeficiency | Journal of clinical immunology | 2021 | 20 | 0 | |||
| Frequent lower respiratory tract disease in hematological patients with parainfluenza virus type 3 infection | Journal of medical virology | 2021 | 42 | 0 | |||
| Pulmonary Alveolar Proteinosis After Allogeneic Hematopoietic Stem-Cell Transplantation in Adults : A French Société Francophone de Greffe de Moelle et Thérapie Cellulaire Survey | Chest | 2021 | 30 | 67 | |||
| Prospective comparison of (1,3)-beta-D-glucan detection using colorimetric and turbidimetric assays for diagnosing invasive fungal disease | Medical mycology | 2021 | 35 | 32 | |||
| Granulomatous-lymphocytic interstitial lung disease : an international research prioritisation | ERJ open research | 2021 | 31 | 24 | |||
| Un exemple de réorganisation dans le fonctionnement d’un Centre d’investigations cliniques en période de confinement national suite à la pandémie COVID-19 | Thérapie | 2021 | 323 | 325 | |||
| Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia : A Randomized Clinical Trial | JAMA internal medicine | 2021 | 54 | 91 | |||
| Management of early infection with Pseudomonas aeruginosa in adults with bronchiectasis : A survey of French pulmonologist's practices | Respiratory medicine and research | 2021 | 32 | 0 | |||
| Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1) : a randomised controlled trial | The Lancet. Respiratory medicine | 2021 | 58 | 24 | |||
| Bayesian survival analysis for early detection of treatment effects in phase 3 clinical trials | Contemporary clinical trials communications | 2021 | 54 | 73 | |||
| Functional assessment and phenotypic heterogeneity of SFTPA1 and SFTPA2 mutations in interstitial lung diseases and lung cancer | The European respiratory journal | 2020 | 10 | 130 | |||
| Managing Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders : e-GLILDnet International Clinicians Survey | Frontiers in immunology | 2020 | 44 | 76 | |||
| A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory Tract | Clinical infectious diseases | 2020 | 36 | 69 | |||
| Pneumocytis jirovecii et PCR quantitative : pneumonie ou colonisation à Pneumocystis jirovecii ? | Revue des maladies respiratoires | 2020 | 39 | 0 | |||
| Azithromycin Use and Increased Cancer Risk among Patients with Bronchiolitis Obliterans after Hematopoietic Cell Transplantation | Biology of blood and marrow transplantation | 2020 | 34 | 188 | |||
| Pleuroparenchymal fibroelastosis after allogeneic hematopoietic stem cell transplantation | Bone marrow transplantation | 2020 | 65 | 0 | |||
| Effect of Ruxolitinib on Lung Function after Allogeneic Stem Cell Transplantation | Biology of blood and marrow transplantation | 2020 | 8 | 26 | |||
| Complement C5 inhibition in patients with COVID-19 - a promising target ? | Haematologica | 2020 | 10 | 31 | |||
| Pulmonary complications of Bcr-Abl tyrosine kinase inhibitors | The European respiratory journal | 2020 | 9 | 50 | |||
| A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients | Clinical infectious diseases | 2020 | 28 | 27 | |||
| Lower respiratory tract amyloidosis : Presentation, survival and prognostic factors. A multicenter consecutive case series | American journal of hematology | 2019 | 9 | 3 | |||
| Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. A position paper by the European Conference on Infections in Leukemia (ECIL) | Leukemia | 2019 | 7 | 16 | |||
| Noninfectious lung complications after allogeneic haematopoietic stem cell transplantation | The European respiratory journal | 2018 | 8 | 6 | |||
| Lung histopathology of non-infectious pulmonary complications after allogeneic haematopoietic stem cell transplantation | Histopathology | 2018 | 8 | 0 | |||
| Dermatopulmonary Syndrome Associated With Anti-MDA5 Antibodies After Allogeneic Hematopoietic Stem Cell Transplantation | JAMA dermatology | 2017 | 6 | 0 | |||
| Circulating Aspergillus fumigatus DNA Is Quantitatively Correlated to Galactomannan in Serum | Frontiers in microbiology | 2017 | 11 | 42 | |||
| Azithromycin and Survival After Hematopoietic Stem Cell Transplant-Reply | JAMA | 2017 | 8 | 0 | |||
| Bosutinib-related pneumonitis | The European respiratory journal | 2017 | 10 | 30 | |||
| Long-term outcomes of dasatinib-induced pulmonary arterial hypertension : a population-based study | The European respiratory journal | 2017 | 7 | 25 | |||
| Effect of Azithromycin on Airflow Decline-Free Survival After Allogeneic Hematopoietic Stem Cell Transplant : The ALLOZITHRO Randomized Clinical Trial | JAMA | 2017 | 10 | 0 | |||
| Idelalisib-related pneumonitis | The European respiratory journal | 2016 | 12 | 22 | |||
| APRIL levels are associated with disease activity in human chronic graft-versus-host disease | Haematologica | 2016 | 9 | 4 | |||
| Reply to "Early Lung Computed Tomography Scan after Allogeneic Hematopoietic Stem Cell Transplantation" | Biology of blood and marrow transplantation | 2016 | 9 | 6 | |||
| Early Lung Computed Tomography Scan after Allogeneic Hematopoietic Stem Cell Transplantation | Biology of blood and marrow transplantation | 2016 | 10 | 11 | |||
| CD24hiCD27⁺ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease | Blood | 2015 | 11 | 5 | |||
| Budesonide/Formoterol for bronchiolitis obliterans after hematopoietic stem cell transplantation | American journal of respiratory and critical care medicine | 2015 | 7 | 187 | |||
| Phenotyping chronic pulmonary aspergillosis by cluster analysis | The European respiratory journal | 2015 | 8 | 9 | |||
| Late-onset noninfectious interstitial lung disease after allogeneic hematopoietic stem cell transplantation | Respiratory medicine | 2014 | 7 | 3 | |||
| Viral respiratory infections diagnosed by multiplex PCR after allogeneic hematopoietic stem cell transplantation : long-term incidence and outcome | Biology of blood and marrow transplantation | 2014 | 7 | 2 | |||
| Use and limits of (1-3)-β-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis | Journal of clinical microbiology | 2014 | 8 | 4 | |||
| Human metapneumovirus pneumonia in patients with hematological malignancies | Journal of clinical virology | 2014 | 8 | 32 | |||
| Small airways diseases, excluding asthma and COPD : an overview | European respiratory review | 2013 | 7 | 11 | |||
| Prospective evaluation of clinical and biological markers to predict the outcome of invasive pulmonary aspergillosis in hematological patients | Journal of clinical microbiology | 2012 | 8 | 5 | |||
| The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies | Blood | 2012 | 7 | 22 | |||
| Pulmonary arterial hypertension in patients treated by dasatinib | Circulation | 2012 | 6 | 8 | |||
| Persistent poor long-term prognosis of allogeneic hematopoietic stem cell transplant recipients surviving invasive aspergillosis | Haematologica | 2012 | 7 | 11 | |||
| Severe chronic bronchiolitis as the presenting feature of primary Sjögren's syndrome | Respiratory medicine | 2011 | 8 | 5 |
